These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17571110)

  • 21. [Adverse events related to substitution of generic products in Norway 2005].
    Reppe LA; Stenberg-Nilsen H; Harg P; Hegge AB; Lillefloth AK; Buajordet I
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2696-700. PubMed ID: 19079413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Confusion over counterfeit drugs in Uganda.
    Anderson T
    Lancet; 2009 Jun; 373(9681):2097-8. PubMed ID: 19551913
    [No Abstract]   [Full Text] [Related]  

  • 23. New rules on medicines.
    Hardy BD
    Vet Rec; 1995 Jan; 136(4):107. PubMed ID: 7740719
    [No Abstract]   [Full Text] [Related]  

  • 24. US drug regulator rejects accusations that it unfairly targets Indian generic firms.
    Bagcchi S
    BMJ; 2014 Mar; 348():g1845. PubMed ID: 24591464
    [No Abstract]   [Full Text] [Related]  

  • 25. [Patients, patents and profits].
    Roland PC
    Tidsskr Nor Laegeforen; 2008 Jan; 128(2):205. PubMed ID: 18202741
    [No Abstract]   [Full Text] [Related]  

  • 26. Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Jul; 74(143):37163-8. PubMed ID: 19655468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The Medical Products Agency and testosterone treatment. Act II].
    Lindholm J
    Ugeskr Laeger; 2005 May; 167(20):2200; author reply 2200. PubMed ID: 15987085
    [No Abstract]   [Full Text] [Related]  

  • 28. What is a truly innovative drug? New definition from the International Society of Drug Bulletins.
    Kopp C
    Can Fam Physician; 2002 Sep; 48():1413-5, 1424-6. PubMed ID: 12371294
    [No Abstract]   [Full Text] [Related]  

  • 29. [The Medical Products Agency and testosterone treatment. The 3rd and the last act].
    Lindholm J
    Ugeskr Laeger; 2005 Aug; 167(33):3072-4. PubMed ID: 16109265
    [No Abstract]   [Full Text] [Related]  

  • 30. [Changing the medical record or the law?].
    Dammert U
    Lakartidningen; 2007 Jul 25-Aug 7; 104(30-31):2179. PubMed ID: 17828844
    [No Abstract]   [Full Text] [Related]  

  • 31. [Monitoring of undesired effects of drugs in pediatric practice].
    Uhlír O
    Cesk Pediatr; 1973 Mar; 28(3):141-3. PubMed ID: 4694459
    [No Abstract]   [Full Text] [Related]  

  • 32. [Mandatory information and cheaper drugs].
    Faye A
    Tidsskr Nor Laegeforen; 1995 Nov; 115(29):3662. PubMed ID: 8539732
    [No Abstract]   [Full Text] [Related]  

  • 33. [The intercantonal drug control office at the service of physicians].
    Flury W
    Ther Umsch; 1982 Nov; 39(11):925-7. PubMed ID: 7179176
    [No Abstract]   [Full Text] [Related]  

  • 34. Do international model drug control laws provide for drug availability?
    University of Wisconsin Pain & Policy Studies Group
    J Pain Palliat Care Pharmacother; 2009; 23(2):145-52. PubMed ID: 19492215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generic substitution: additional challenge for adherence in hypertensive patients?
    Håkonsen H; Eilertsen M; Borge H; Toverud EL
    Curr Med Res Opin; 2009 Oct; 25(10):2515-21. PubMed ID: 19708764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Old drugs, new possibilities].
    Raknes G
    Tidsskr Nor Laegeforen; 2008 Jan; 128(1):62-5. PubMed ID: 18183061
    [No Abstract]   [Full Text] [Related]  

  • 37. [Biosimilar products--cheaper version of biological drugs. New possibilities within several therapeutic fields].
    Mellstedt H
    Lakartidningen; 2009 Jun 3-9; 106(23):1563-6. PubMed ID: 19583014
    [No Abstract]   [Full Text] [Related]  

  • 38. [Internet pharmacies and counterfeit drugs].
    Schweim JK; Schweim HG
    Med Klin (Munich); 2009 Feb; 104(2):163-9. PubMed ID: 19242667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A marketing documentation center].
    Henin S
    Ann Ist Super Sanita; 1986; 22(4):1335-6. PubMed ID: 3827049
    [No Abstract]   [Full Text] [Related]  

  • 40. Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Sep; 73(189):56487-91. PubMed ID: 18985960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.